Ñî¹óåú´«Ã½

First-Line Drug Therapy for Type 2 Diabetes

Annals on Call

In this episode of Annals On Call, Dr. Centor discusses the cost-effectiveness of sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes with Drs. Neda Laiteerapong and Aaron Winn.

First, . After listening, ACP members can for free.

CME/MOC:

Up to 1 AMA PRA Category 1 Credits ™ and MOC Points
Expires February 21, 2026   active

Cost:

Free to Members

Format:

Podcasts and Audio Content

Product:

Annals on Call

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.